Px Wire
Px Wire is AVAC's quarterly update on
biomedical HIV prevention research. Each issue
includes a comprehensive timeline of ongoing
efficacy trials around the world and a map
showing where these trials are happening. Each
issue also includes updates on news, emerging
issues, and upcoming events.
PxWire Archive: to view Px Wire issues starting from January 2008

January-March 2010, Volume 3, Number 1 (PDF)
Highlights in this issue of Px Wire include updates on:
![]()

Download the updated timeline and map of ongoing efficacy trials around the world:
- Timeline (JPG) or (PDF)
- Map (JPG) or (PDF)
PxWire Archive: to view Px Wire issues starting from January 2008
January-March 2010, Volume 3, Number 1 (PDF)
Highlights in this issue of Px Wire include updates on:
- The results from MDP 301, a trial of the microbicide PRO 2000, which lay to rest its prospect as a viable microbicide;
- CDC’s newly modified PrEP trial (TDF2 in Botswana), which changed its status as an efficacy trial to a safety and behavioral study;
- The evolving effort to understand the Thai prime-boost AIDS vaccine results;
- Recent NIH grants that nearly double global spending on rectal microbicides; and
- Timeline of 2010 trial milestones—what trial results are expected and what new studies are scheduled to commence?
Download the updated timeline and map of ongoing efficacy trials around the world:
- Timeline (JPG) or (PDF)
- Map (JPG) or (PDF)




